- GMP
About
Biomay AG is a biopharmaceutical CDMO in Vienna, Austria. It manufactures GMP-grade plasmid DNA, mRNA, recombinant proteins, and related drug products for clinical phases I–III and market supply. The company operates two GMP manufacturing sites in Vienna.
Services
Vector development
Develops vectors for plasmids, proteins, and mRNA.
Cell line development
GMP cell banking
Creates Master Cell Banks and Working Cell Banks.
Cell line development
Process development and feasibility studies
Carries out process development and feasibility work for client projects.
Analytical development / quality control methods
Develops analytical methods and quality control methods for project support.
GMP manufacturing of bulk drug substance
Manufactures bulk drug substance for clinical phases I–III and market supply.
CDMO: development & manufacturing
GMP aseptic filling of drug product
Performs aseptic filling of drug product for clinical phases I–III.
CDMO: development & manufacturing
Quality control and Qualified Person release
Provides quality control and QP release services.
Analytical method and process validation (PPQ)
Supports analytical method validation and process validation activities.
Regulatory support
Provides regulatory support for client programs.
ICH stability testing & long-term storage
Conducts ICH stability testing and long-term storage.
Aseptic filling
Offers cGMP fill & finish services for DNA, proteins, and RNA.
CDMO: development & manufacturing
Personalized manufacturing
Manufactures patient-specific DNA and mRNA cancer vaccines within a few weeks.
CDMO: development & manufacturing
- Turnaround
- Within a couple of weeks · From incoming of starting material to released mRNA-LNP in three weeks · From incoming of starting material to released plasmid DNA in two weeks · Personalized DNA cancer vaccines in as little as two weeks · mRNA-based vaccines in approximately three weeks
- What to send
- In-silico sequence of individual patient mRNA provided by sponsor · DNA fragment synthesis as starting material (external) · In-silico sequence of individual patient DNA provided by sponsor
Capabilities
- Assays and studies
- mRNA · Fill-finish · LNP · Analytical development · Cell-free expression · Process development · Quality control · Qualified person release · Analytical method validation · Process validation · ICH stability testing · In-house rapid sterility testing
1 more
Assay development - Scale and capacity
- Two GMP manufacturing sites · 10 segregated GMP clean room suites · Total floor space 6000 sqm / 60,000 sq ft · Headquarter facility 4000 sqm total floor space · mRNA Competence Center 2000 sqm total floor space · Bioreactor capacities: 30L, 50L, 150L, 750L · Personalized bioreactor capacities: 4 x 3L · Capacity up to 1500 2R glass vials per batch · Up to 1500 sterile-filled vials per batch · Up to 50 mg mRNA per patient · Up to 300 mg DNA per patient
- Therapeutic areas
- Cancer immunotherapy · Gene editing · ATMPs
Instruments and platforms
- Automated filling / stoppering line
- High-pressure homogenizers
- Centrifuges
- Process chromatography equipment
Modalities and species
- Modalities
- mRNA · Viral vector · Gene editing · Recombinant protein · Vaccine · Plasmid DNA · LNP / formulation
- Species and models
- E. coli
Certifications
As the company states them, with the certificate or registry record where there is one.
GMPSelf-reported
Scope: plasmid DNA, mRNA, recombinant proteins, aseptic filling, personalized batches
Company
- Type
- CDMO
- Founded
- 1984
Locations
- Address
- Ada-Lovelace-Straße 2; 1220 Vienna, Austria
- Sites
- Vienna, Austria · Vienna 1220 (Aspern Seestadt), Austria · Vienna 1090, Austria
- Serves
- North America
Public records
- Parent company
- BIOMAY AG · AT GLEIF
Similar labs
Work here? Claim this listing